Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eli Lilly

771.75
-27.5900-3.45%
Pre-market: 773.331.58+0.20%08:26 EDT
Volume:4.17M
Turnover:3.25B
Market Cap:731.41B
PE:62.80
High:805.42
Open:801.67
Low:764.38
Close:799.34
Loading ...

LLY's Q1 Earnings Miss, Mounjaro & Zepbound Drive Sales, Stock Down

Zacks
·
01 May

BRIEF-Eli Lilly Reports Pre-Launch Inventories Capitalized As Of March 31, 2025 $601.4 Million, Primarily Related To Orforglipron - Filing

Reuters
·
01 May

Eli Lilly: Pre-Launch Inventories Capitalized as of March 31, 2025 $601.4 Mln

THOMSON REUTERS
·
01 May

Eli Lilly CEO Urges Trump to Ease Up on Tariffs, Extend 2017 Tax Cuts -- WSJ

Dow Jones
·
01 May

BUZZ-Eli Lilly falls after CVS move to drop Zepbound reimbursement coverage

Reuters
·
01 May

BRIEF-Lilly Exec Says Tariffs Currently In Effect Do Not Materially Change 2025 Financial Outlook

Reuters
·
01 May

EXCLUSIVE-WHO to back use of weight-loss drugs for adults globally, raises cost issue

Reuters
·
01 May

Eli Lilly Exec Says Announced Tariffs Currently in Effect Do Not Materially Change Co's 2025 Financial Outlook - Conf Call

THOMSON REUTERS
·
01 May

Lilly Exec Says Expect US Regulatory Action for Modified Dosing Regime for Alzheimer's Drug Kisunla in the Next Few Months

THOMSON REUTERS
·
01 May

Lilly Exec Says Plans to Start a New Late-Stage Trial for Its Drug Retatrutide in Patients With Obesity and Chronic Low Back Pain

THOMSON REUTERS
·
01 May

Lilly Exec Says Recently Initiated Limited Mounjaro Launch in China, Expect to to Gradually Increase Launch in H2 as Supply Becomes Available

THOMSON REUTERS
·
01 May

Lilly Exec Says Expansion of Tariffs in Other Geographies or Increases in Retaliatory Tariffs Would Have a Negative Effect on Co, Industry

THOMSON REUTERS
·
01 May

Lilly Exec Says Co Has Withdrawn US Application for Heart Failure With Preserved Ejection Fraction Indication for Tirzepatide

THOMSON REUTERS
·
01 May

Stock Track | Eli Lilly Plunges 7.29% Pre-Market on Lowered Guidance and CVS Health's Wegovy Deal

Stock Track
·
01 May

Pharma Stocks Sank. Eli Lilly Fell 7%; Moderna Fell 5%; Novavax And BioNTech Fell 4%; Viking Fell 2%

Tiger Newspress
·
01 May

Mounjaro Maker Eli Lilly Clocks 45% Jump In Q1 Revenue, Cuts 2025 Profit Outlook But Not Due To Tariffs

Benzinga
·
01 May

Eli Lilly Shares Down 5.8% After CVS Health to Drop Co's Obesity Drug Zepbound Coverage

THOMSON REUTERS
·
01 May

Eli Lilly and Co reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
01 May

Here's What Key Metrics Tell Us About Lilly (LLY) Q1 Earnings

Zacks
·
01 May

Eli Lilly Lowers 2025 Earnings Outlook Despite Stronger-Than-Expected First-Quarter Results

MT Newswires
·
01 May